Transcend Medical

Transforming the treatment of glaucoma.

[Transcend Medical @TranscendMed]

Transcend joining @Novartis Alcon tops OIS News in Feb : Eye on Five https://t.co/bqyjTBF5KF via @oistweets

[Transcend Medical @TranscendMed]

Check out our CMO, Sean Ianchulev, presenting at last year's OIS meeting at AAO in Las Vegas @OISTWEETS @aao_ophth https://t.co/hI28WyzXtb

[Transcend Medical @TranscendMed]

Thx @canaanpartners, @WendeHutton, & all our investors for your support of the CyPass #glaucoma therapy https://t.co/nwFQcK3Q5i @MDDIonline

[Transcend Medical @TranscendMed]

Transcend is proud to announce we will be joining @Novartis #Alcon, world leader in eye care. https://t.co/n2i8m0SdkN #glaucoma #MIGS

[Transcend Medical @TranscendMed]

What do #glaucoma and other blinding conditions really look like? Check out https://t.co/mh6dd4f0rP via @medicaldaily

[Transcend Medical @TranscendMed]

MIGS in the suprachoroidal space: three reasons why it has a bright future @DrHovanesian @Healio_OSN https://t.co/eHr7M73qBs

[Ophthalmology Innovation Source @OISTWEETS]

Transcend @TranscendMed announced it had submitted the final module of its PMA application - https://t.co/WnOJtEyii3

[Transcend Medical @TranscendMed]

Sean Ianchulev MD describes the potential of supraciliary microstenting with the CyPass Micro-Stent #MIGS #glaucoma http://t.co/Fw0g1zFZMB

[Transcend Medical @TranscendMed]

CyPass AJO article on DUETTE study (multicenter trial on standalone procedure) covered in recent @Healio_OSN! http://t.co/3pdB4Hn0YS

[Transcend Medical @TranscendMed]

Transcend is proud to be featured on the latest OIS podcast. http://t.co/VE6ldJKiIH via @oistweets

[Transcend Medical @TranscendMed]

CyPass Micro-Stent US-IDE pivotal study positive; next glaucoma stent to file PMA with FDA late 2015. http://t.co/2RnLIRqclA

[Transcend Medical @TranscendMed]

@GlaucomaWeek It's World Glaucoma Week! Get yourself or a loved one screened if you are at risk. Find out more http://t.co/I4BjBWTQRt

[Ophthalmology Innovation Source @OISTWEETS]

VP of @TranscendMed gives his opinon on the OIS meetings http://t.co/3PlDH06pa0 courtesy of @EWNews #Ophthalmology #Innovation

[NEI @NatEyeInstitute]

#Glaucoma runs in families. Ask your family about their eye health.

[Transcend Medical @TranscendMed]

Our favorite CEO Brian Walsh & the CyPass Micro-Stent "transcending glaucoma treatment" featured in @MassDevice! http://t.co/LGqnWglb0j

[Canaan @canaanpartners]

.@TranscendMed Raises $22M Series C to transform the treatment of glaucoma. http://t.co/RwoZEIpDwg

[MassDevice @MassDevice]

Transcend Medical closes on $22M Series C round | MassDevice http://t.co/PCI3ygHE9M

[Transcend Medical @TranscendMed]

We are proud to announce the closing of a $22M Series C financing to help us complete the COMPASS U.S. pivotal study! http://t.co/aT1LDRtkCr

[Transcend Medical @TranscendMed]

Our CMO, Dr. Sean Ianchulev, speaking at @GlaucomaOrg @PalaceHotelSF with a CyPass Micro-Stent update. Nice job Sean!

[Transcend Medical @TranscendMed]

2-year CyPass Micro-Stent data from our European study, published in the Ophthalmology Times, and featuring our... http://t.co/3ce1lwJwSz